260 related articles for article (PubMed ID: 15720786)
1. Synthesis of baicalein derivatives as potential anti-aggregatory and anti-inflammatory agents.
Huang WH; Lee AR; Chien PY; Chou TC
J Pharm Pharmacol; 2005 Feb; 57(2):219-25. PubMed ID: 15720786
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibitory effects of baicalein and baicalin on LPS-induced cyclooxygenase-2 expression through inhibition of C/EBPbeta DNA-binding activity.
Woo KJ; Lim JH; Suh SI; Kwon YK; Shin SW; Kim SC; Choi YH; Park JW; Kwon TK
Immunobiology; 2006; 211(5):359-68. PubMed ID: 16716805
[TBL] [Abstract][Full Text] [Related]
4. The evaluation and structure-activity relationships of 2-benzoylaminobenzoic esters and their analogues as anti-inflammatory and anti-platelet aggregation agents.
Hsieh PW; Hwang TL; Wu CC; Chiang SZ; Wu CI; Wu YC
Bioorg Med Chem Lett; 2007 Mar; 17(6):1812-7. PubMed ID: 17197180
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory activity of the synthetic C-C biflavonoids.
Park H; Kim YH; Chang HW; Kim HP
J Pharm Pharmacol; 2006 Dec; 58(12):1661-7. PubMed ID: 17331331
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-platelet activity of obovatol derivatives.
Kwak JH; Lee S; Park ES; In JK; Song J; Kim YJ; Choi NS; Lee H; Yun YP; Hong JT; Kwak YS; Min KH; Jung JK
Arch Pharm Res; 2011 Jul; 34(7):1107-12. PubMed ID: 21811917
[TBL] [Abstract][Full Text] [Related]
8. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of copper-aspirin complex on platelet aggregation.
Shen ZQ; Chen ZH; Ma GY; Wang DC; Wu WL; Liu WP; Yang YK; Xiong HZ
Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):358-62. PubMed ID: 10072923
[TBL] [Abstract][Full Text] [Related]
10. Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 macrophages.
Kim KW; Ha KT; Park CS; Jin UH; Chang HW; Lee IS; Kim CH
Vascul Pharmacol; 2007; 47(2-3):99-107. PubMed ID: 17553752
[TBL] [Abstract][Full Text] [Related]
11. Effect of acetylsalicylic acid on aggregation of human platelets by Porphyromonas gingivalis.
Whitaker EJ; Thomas IS; Falk JA; Obebe A; Hammond BF
Gen Dent; 2007; 55(1):64-9; quiz 70, 79-80. PubMed ID: 17333971
[TBL] [Abstract][Full Text] [Related]
12. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of 2,8-disubstituted benzoxazinone derivatives as anti-inflammatory and anti-platelet aggregation agents.
Hsieh PW; Hwang TL; Wu CC; Chang FR; Wang TW; Wu YC
Bioorg Med Chem Lett; 2005 Jun; 15(11):2786-9. PubMed ID: 15878278
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparations.
Buccellati C; Sala A; Rossoni G; Capra V; Rovati GE; Di Gennaro A; Folco G; Colli S; Casagrande C
J Pharmacol Exp Ther; 2006 May; 317(2):830-7. PubMed ID: 16399881
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, platelet anti-aggregating activity and anti-inflammatory activity of a series of beta-aminoxypropionic acids.
Macchia M; Orlandini E; Rossello A; Bertini S; Soldani G; Baldacci M; Gervasi G
Farmaco; 1994 Dec; 49(12):767-73. PubMed ID: 7893333
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages.
Kanno S; Shouji A; Tomizawa A; Hiura T; Osanai Y; Ujibe M; Obara Y; Nakahata N; Ishikawa M
Life Sci; 2006 Jan; 78(7):673-81. PubMed ID: 16137700
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs.
Hsieh PW; Chiang SZ; Wu CC; Lo YC; Shih YT; Wu YC
Bioorg Med Chem; 2008 May; 16(10):5803-14. PubMed ID: 18407506
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel and potent small-molecule inhibitors of NO and cytokine production as antisepsis agents: synthesis and biological activity of alkyl 6-(N-substituted sulfamoyl)cyclohex-1-ene-1-carboxylate.
Yamada M; Ichikawa T; Ii M; Sunamoto M; Itoh K; Tamura N; Kitazaki T
J Med Chem; 2005 Nov; 48(23):7457-67. PubMed ID: 16279805
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and crystallographic analysis of benzophenone derivatives--the potential anti-inflammatory agents.
Venu TD; Shashikanth S; Khanum SA; Naveen S; Firdouse A; Sridhar MA; Shashidhara Prasad J
Bioorg Med Chem; 2007 May; 15(10):3505-14. PubMed ID: 17376692
[TBL] [Abstract][Full Text] [Related]
20. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
